These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9598774)

  • 1. An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli.
    Horii T; Kobayashi M; Sato K; Ichiyama S; Ohta M
    J Antimicrob Chemother; 1998 Apr; 41(4):435-42. PubMed ID: 9598774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between morphological changes and endotoxin release induced by carbapenems in Pseudomonas aeruginosa.
    Horii T; Ichiyama S; Ohta M; Kobayashi M
    J Med Microbiol; 1999 Mar; 48(3):309-315. PubMed ID: 10334599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects.
    Trautmann M; Heinemann M; Zick R; Möricke A; Seidelmann M; Berger D
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):754-60. PubMed ID: 9923514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-induced endotoxin release in gram-negative bacterial sepsis rat models.
    Horii T; Kobayashi M; Nadai M; Ichiyama S; Ohta M
    FEMS Immunol Med Microbiol; 1998 Aug; 21(4):297-302. PubMed ID: 9753002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
    Shibata K; Adachi Y; Kato E; Nagano R; Fuse A; Hashizume T; Ohtake N; Okamoto O; Nakagawa S
    J Antibiot (Tokyo); 1997 Feb; 50(2):135-8. PubMed ID: 9099222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Christenson JC; Korgenski EK; Daly JA
    J Antimicrob Chemother; 2000 Jun; 45(6):899-901. PubMed ID: 10837448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
    Valenza G; Seifert H; Decker-Burgard S; Laeuffer J; Morrissey I; Mutters R;
    Int J Antimicrob Agents; 2012 Mar; 39(3):255-8. PubMed ID: 22230334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal models.
    Tsuji M; Matsuda H; Miwa H; Miyazaki S
    J Antimicrob Chemother; 2003 Feb; 51(2):353-9. PubMed ID: 12562702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
    Watanabe A; Tokue Y; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Yasui S; Nukiwa T; Shoji S; Honda Y
    Jpn J Antibiot; 1999 Dec; 52(12):690-4. PubMed ID: 10695024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
    Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
    Bauernfeind A; Jungwirth R; Schweighart S
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():73-84. PubMed ID: 2509418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
    Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
    Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bactericidal activity of biapenem against various efflux system mutants of Pseudomonas aeruginosa].
    Hiraishi T; Miyata A; Takata T; Araake M; Ogawa H; Gotoh N; Nishino T
    Jpn J Antibiot; 2002 Feb; 55(1):67-76. PubMed ID: 11977922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of exotoxin A, peptidoglycan and endotoxin after exposure of clinical Pseudomonas aeruginosa isolates to carbapenems in vitro.
    Horii T; Muramatsu H; Monji A; Miyagishima D
    Chemotherapy; 2005 Oct; 51(6):324-31. PubMed ID: 16224183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide.
    Yokochi T; Kusumi A; Kido N; Kato Y; Sugiyama T; Koide N; Jiang GZ; Narita K; Takahashi K
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2410-2. PubMed ID: 8891153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postantibiotic effect of carbapenems against Pseudomonas aeruginosa.
    Hikida M; Yamazaki Y; Yoshida M; Kawashima K; Nishiki K; Mitsuhashi S
    J Antibiot (Tokyo); 1995 Aug; 48(8):891-2. PubMed ID: 7592037
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with Cancer.
    Hachem R; Reitzel R; Rolston K; Chaftari AM; Raad I
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro antibacterial activity and beta-lactamase stability of meropenem].
    Poiată A; Tuchiluş C; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):589-94. PubMed ID: 14756067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antibacterial activities of carbapenems against clinical isolates].
    Murase M
    Jpn J Antibiot; 1999 Nov; 52(11):667-79. PubMed ID: 10659443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bactericidal activity of biapenem against various bacteria].
    Hiraishi T; Miyata A; Hara T; Araake M; Ogawa H
    Jpn J Antibiot; 2001 Dec; 54(12):581-95. PubMed ID: 11877858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.